91 related articles for article (PubMed ID: 11769361)
1. [Antipsychotic drugs can affect hormone balance. Weight gain, blood lipid disturbances and diabetes are important].
Melkersson K; Hulting AL
Lakartidningen; 2001 Nov; 98(48):5462-4, 5467-9. PubMed ID: 11769361
[TBL] [Abstract][Full Text] [Related]
2. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
3. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics.
Hägg S; Söderberg S; Ahrén B; Olsson T; Mjörndal T
J Clin Psychiatry; 2001 Nov; 62(11):843-8. PubMed ID: 11775042
[TBL] [Abstract][Full Text] [Related]
4. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
[TBL] [Abstract][Full Text] [Related]
5. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
[TBL] [Abstract][Full Text] [Related]
6. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
Melkersson KI; Hulting AL
Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
[TBL] [Abstract][Full Text] [Related]
7. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Melkersson K; Berinder K; Hulting AL
Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
[TBL] [Abstract][Full Text] [Related]
9. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
11. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
12. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
13. [Diabetes mellitus type II--induced by "atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):312-22. PubMed ID: 12796851
[TBL] [Abstract][Full Text] [Related]
14. [Hyperlipidemia - side-effect of "Atypical" neuroleptics?].
Wetterling T
Fortschr Neurol Psychiatr; 2003 Oct; 71(10):535-40. PubMed ID: 14551854
[TBL] [Abstract][Full Text] [Related]
15. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
Henderson DC
J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
[TBL] [Abstract][Full Text] [Related]
16. Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia.
Kivircik BB; Alptekin K; Calişkan S; Cömlekçi A; Orük G; Tümüklü M; Kürklü K; Arkar H; Türk A; Calişkan M; Yeşil S
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):795-9. PubMed ID: 12921912
[TBL] [Abstract][Full Text] [Related]
17. The implications of weight changes with antipsychotic treatment.
Sussman N
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
[TBL] [Abstract][Full Text] [Related]
18. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
Huang TL; Lu CY
Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
[TBL] [Abstract][Full Text] [Related]
19. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
20. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
Koponen H; Saari K; Savolainen M; Isohanni M
Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
